Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Part I: Gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies

Journal of the American College of Cardiology

Volumn 47, Issue 3 SUPPL., 2006, Pages S4-S20

  Shaw, Leslee J ^a,c   Bairey Merz, C Noel ^a   Pepine, Carl J ^d   Reis, Steven E ^b   Bittner, Vera ^g   Kelsey, Sheryl F ^c   Olson, Marian ^c   Johnson, B Delia ^c   Mankad, Sunil ^e   Sharaf, Barry L ^f   Rogers, William J ^g   Wessel, Timothy R ^d   Arant, Christopher B ^d   Pohost, Gerald M ^h   Lerman, Amir ⁱ   Quyyumi, Arshed A ^j   Sopko, George ^k  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^f RHODE ISLAND HOSPITAL   (United States)

^g University of Alabama at Birmingham   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ MAYO CLINIC   (United States)

^j EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; SEX HORMONE;

CAUSE OF DEATH; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISABILITY; EXERCISE ELECTROCARDIOGRAPHY; HEALTH CARE ORGANIZATION; HORMONE ACTION; HUMAN; ISCHEMIA; ISCHEMIC HEART DISEASE; META ANALYSIS; MORTALITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOKING CESSATION; SPECTROSCOPY; STRESS ECHOCARDIOGRAPHY; SYSTEMATIC REVIEW; TECHNIQUE;

EID: 31644443751     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.01.072     Document Type: Review

References (195)

1. C.N. Merz, R. Bonow, G. Sopko National Heart, Lung, and Blood Institute (NHLBI) Women's Ischemia Syndrome Evaluation workshop executive summary Circulation 109 2004 805 807
2. American Heart Association. Heart Disease and Stroke Statistics: 2004 Update. http://americanheart.org/downloadable/heart/ 1072969766940HSStats2004Update.pdf. Accessed January 15, 2004.
3. L. Mosca, L.J. Appel, E.J. Benjamin American Heart Association evidence-based guidelines for cardiovascular disease prevention in women expert panel/writing group Circulation 109 2004 672 693
4. D.J. Lerner, W.B. Kannel Patterns of coronary heart disease morbidity and mortality in the sexes a 26-year follow-up of the Framingham population Am Heart J 111 1986 383 390
5. Make Every Mother and Child Count. Available at: www.cdc.gov/od/ spotlight/nwhw/whlth05.htm. Accessed November 23, 2005.
6. B. Healy The Yentl syndrome N Engl J Med 325 1991 274 276
7. D.B. Mark, L.K. Shaw, E.R. DeLong, R.M. Califf, D.B. Pryor Absence of sex bias in the referral of patients for cardiac catheterization N Engl J Med 330 1994 1101 1106
8. L.J. Shaw, D.D. Miller, J.C. Romeis, D. Kargl, L.T. Younis, B.R. Chaitman Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease Ann Intern Med 120 1994 559 566
9. R.M. Steingart, M. Packer, P. Hamm Sex differences in the management of coronary artery disease. Survival And Ventricular Enlargement Investigators N Engl J Med 325 1991 226 230
10. P.K. Kilaru, R.F. Kelly, J.E. Calvin, J.E. Parillo Utilization of coronary angiography and revascularization after acute myocardial infarction in men and women risk stratified by the American College of Cardiology/American Heart Association guidelines J Am Coll Cardiol 35 2000 974 979
11. J.N. Tobin, S. Wassertheil-Smoller, J.P. Wexler Sex bias in considering coronary bypass surgery Ann Intern Med 107 1987 19 25
12. A. Bowling, M. Bond, D. McKee Equity in access to exercise tolerance testing, coronary angiography, and coronary artery bypass grafting by age, sex and clinical indications Heart 85 2001 680 686
13. D.S. Battleman, M. Callahan Gender differences in utilization of exercise treadmill testing a claims-based analysis J Healthc Qual 23 2001 38 41
14. R.S. Stafford Aspirin use is low among United States outpatients with coronary artery disease Circulation 101 2000 1097 1101
15. S.S. Rathore, J. Chen, Y. Wang, M.J. Radford, V. Vaccarino, H.M. Krumholz Sex differences in cardiac catheterization the role of physician gender JAMA 286 2001 2849 2856
16. S.S. Rathore, Y. Wang, M.J. Radford, D.L. Ordin, H.M. Krumholz Sex differences in cardiac catheterization after acute myocardial infarction the role of procedure appropriateness Ann Intern Med 137 2002 487 493
17. A.K. Jha, P.D. Varosy, A.M. Kanaya Differences in medical care and disease outcomes among black and white women with heart disease Circulation 108 2003 1089 1094
18. A.M. Epstein, J.S. Weissman, E.C. Schneider, C. Gatsonis, L.L. Leape, R.N. Piana Race and gender disparities in rates of cardiac revascularization do they reflect appropriate use of procedures or problems in quality of care? Med Care 41 2003 1240 1255
19. T.B. Ferguson Jr., B.G. Hammill, E.D. Peterson, E.R. DeLong, F.L. Grover STS National Database Committee A decade of change - risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons Ann Thorac Surg 73 2002 480 490
20. E.J. Benjamin, S.C. Smith Jr., R.S. Cooper, M.N. Hill, R.V. Luepker Task force #1 - magnitude of the prevention problem opportunities and challenges 33rd Bethesda conference J Am Coll Cardiol 40 2002 588 603
21. V.L. Roger, S.J. Jacobsen, S.A. Weston Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994 Ann Intern Med 136 2002 341 348
22. D.M. Bell, J. Nappi Myocardial infarction in women a critical appraisal of gender differences in outcomes Pharmacotherapy 20 2000 1034 1044
23. S.L. Murphy Death final data for 1998 Natl Vital Stat Rep 48 2000 1 105
24. R. Lampert, C.A. McPherson, J.F. Clancy, T.L. Caulin-Glaser, L.E. Rosenfeld, W.P. Batsford Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter- defibrillators J Am Coll Cardiol 43 2004 2293 2299
25. Centers for Disease Control and Prevention State-Specific Mortality from Sudden Cardiac Death - United States 1999 Available at: http://www.cdc.gov/mmwr/ preview/mmwrhtml/mm5106a3.htm. Updated June 15, 2002. Accessed March 1, 2004
26. V. Vaccarino, L. Parsons, N.R. Every, H.V. Barron, H.M. Krumholz National Registry of Myocardial Infarction 2 participants Sex-based differences in early mortality after myocardial infarction N Engl J Med 341 1999 217 225
27. E.G. Nabel, H.P. Selker, R.M. Califf Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002; section 3: diagnosis and treatment of acute cardiac ischemia: gender issues Circulation 109 2004 e50 e52
28. J.M. Walsh, M. Pignone Drug treatment of hyperlipidemia in women JAMA 291 2004 2243 2252
29. V. Vaccarino, H.M. Krumholz, J. Yarzebski, J.M. Gore, R.J. Goldberg Sex differences in 2-year mortality after hospital discharge for myocardial infarction Ann Intern Med 134 2001 173 181
30. A. Nohria, V. Vaccarino, H.M. Krumholz Gender differences in mortality after myocardial infarction. Why women fare worse than men Cardiol Clin 16 1998 45 57
31. B. Lagerqvist, K. Safstrom, E. Stahle, L. Wallentin, E. Swahn FRISC II Study Group Investigators Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Study Group Investigators J Am Coll Cardiol 38 2001 41 48
32. J. Stamler, M.L. Daviglus, D.B. Garside, A.R. Dyer, P. Greenland, J.D. Neaton Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity JAMA 284 2000 311 318
33. WOSCOPS Study Group West of Scotland Coronary Prevention study identification of high-risk groups and comparison with other cardiovascular intervention trials Lancet 348 1996 1339 1342
34. A. Ariyo, C.H. Hennekens, M.J. Stampfer, P.M. Ridker Lipoprotein (a)lipids, aspirin, and risk of myocardial infarction in the Physician's Health study J Cardiovasc Risk 5 1998 273 278
35. J.G. O'Meara, S.L. Kardia, J.J. Armon, C.A. Brown, E. Boerwinkle, S.T. Turner Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study Arch Intern Med 164 2004 1313 1318
36. A. Britton, M. Shipley, M. Marmot, H. Hemingway Does access to cardiac investigation and treatment contribute to social and ethnic differences in coronary heart disease? Whitehall II prospective cohort study BMJ 329 2004 318
37. A. Britton, M. Shipley, M. Marmot Individual- and area-level socioeconomic status variables as predictors of mortality in a cohort of 179,383 persons Am J Epidemiol 159 2004 1047 1056
38. S.V. Rao, P. Kaul, L.K. Newby Poverty, process of care, and outcome in acute coronary syndromes J Am Coll Cardiol 41 2003 1948 1954
39. M.B. Olson, S.F. Kelsey, K. Matthews Symptoms, myocardial ischaemia and quality of life in women results from the NHLBI-sponsored WISE study Eur Heart J 24 2003 1506 1514
40. L. Mosca, S.M. Grundy, D. Judelson American Heart Association/American College of Cardiology AHA/ACC scientific statement: consensus panel statement. Guide to preventive cardiology for women J Am Coll Cardiol 33 1999 1751 1755
41. B. Phillips Bute, J. Mathew, J.A. Blumenthal Female gender is associated with impaired quality of life 1 year after coronary artery bypass surgery Psychosom Med 65 2003 944 951
42. T.J. Arciero, S.J. Jacobsen, G.S. Reeder Temporal trends in the incidence of coronary disease Am J Med 117 2004 228 233
43. K.P. Alexander, L.J. Shaw, L.K. Shaw, E.R. Delong, D.B. Mark, E.D. Peterson Value of exercise treadmill testing in women J Am Coll Cardiol 32 1998 1657 1664
44. A.M. Arruda-Olson, E.M. Juracan, D.W. Mahoney, R.B. McCully, V.L. Roger, P.A. Pellikka Prognostic value of exercise echocardiography in 5,798 patients is there a gender difference? J Am Coll Cardiol 39 2002 625 631
45. T.H. Marwick, L.J. Shaw, M.S. Lauer Economics of Noninvasive Diagnosis (END) Study Group The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease Am J Med 106 1999 172 178
46. D.A. Weiner, T.J. Ryan, L. Parsons Long-term prognostic value of exercise testing in men and women from the Coronary Artery Surgery Study (CASS) registry Am J Cardiol 75 1995 865 870
47. D.A. Weiner, T.J. Ryan, C.H. McCabe Exercise stress testing. Correlations among history of angina, ST-segment response and prevalence of coronary-artery disease in the Coronary Artery Surgery Study (CASS) N Engl J Med 301 1979 230 235
48. L.J. Shaw, G.V. Heller, M.I. Travin Cost analysis of diagnostic testing for coronary artery disease in women with stable chest pain J Nucl Cardiol 6 1999 559 569
49. L.J. Shaw, R.J. Gibbons, B. McCallister Gender differences in extent and severity of coronary disease in the ACC National Cardiovascular Disease registry J Am Coll Cardiol 39 2002 321A
50. B.D. McCallister, L.J. Shaw, K.R. Mitchell The expected rate of normal coronary arteriograms in the cardiac laboratory J Am Coll Cardiol 39 2002 435A
51. J.S. Hochman, J.E. Tamis, T.D. Thompson Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators N Engl J Med 341 1999 226 232
52. S.C. Smith Jr., S.N. Blair, R.O. Bonow AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology Circulation 104 2001 1577 1579
53. V. Stangl, G. Baumann, K. Stangl Coronary atherogenic risk factors in women Eur Heart J 23 2002 1738 1752
54. R.C. Pasternak, J. Abrams, P. Greenland, L.A. Smaha, P.W. Wilson, N. Houston-Miller 34th Bethesda conference: task force #1 - identification of coronary heart disease risk: is there a detection gap? J Am Coll Cardiol 41 2003 1863 1874
55. D.M. Lloyd-Jones, P.W. Wilson, M.G. Larson Framingham risk score and prediction of lifetime risk for coronary heart disease Am J Cardiol 94 2004 20 24
56. D.M. Lloyd-Jones, B.H. Nam, R.B. D'Agostino Sr. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults a prospective study of parents and offspring JAMA 291 2004 2204 2211
57. Centers for Disease Control and Prevention. Available at: www.cdc.gov/nccdphp/burdenbook2004;index.htm. Accessed December 30, 2005.
58. Major Cardiovascular Disease (CVD) During 1997-1999 and Major CVD Hospital Discharge Rates in 1997 Among Women with Diabetes - United States. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/mm5043a2.htm. Accessed November 23, 2005.
59. J.A. Ambrose, R.S. Barua The pathophysiology of cigarette smoking and cardiovascular disease an update J Am Coll Cardiol 43 2004 1731 1737
60. Diverse Populations Collaboration Smoking, body weight, and CHD mortality in diverse populations Prev Med 38 2004 834 840
61. T.A. Manolio, T.A. Pearson, N.K. Wenger, E. Barrett-Connor, G.H. Payne, W.R. Harlan Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop Ann Epidemiol 2 1992 161 176
62. D.S. Freedman, J.D. Otvos, E.J. Jeyarajah Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy the Framingham study Clin Chem 50 2004 1189 1200
63. J.E. Hokanson, M.A. Austin Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein level a meta-analysis of population-based prospective studies J Cardiovasc Risk 3 1996 213 219
64. J.A. Hoff, L. Quinn, A. Sevrukov The prevalence of coronary artery calcium among diabetic individuals without known coronary artery disease J Am Coll Cardiol 41 2003 1008 1012
65. A.M. Kanaya, D. Grady, E. Barrett-Connor Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus a meta-analysis Arch Intern Med 162 2002 1737 1745
66. E.L. Barrett-Connor, B.A. Cohn, D.L. Wingard, S.L. Edelstein Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo study JAMA 265 1991 627 631
67. P. Raggi, L.J. Shaw, D.S. Berman, T.Q. Callister Prognostic value of coronary artery calcium screening in subjects with and without diabetes J Am Coll Cardiol 43 2004 1663 1669
68. J.I. Barzilay, R.A. Kronmal, J.S. Gottdiener The association of fasting glucose levels with congestive heart failure in diabetic adults > or = 65 years the Cardiovascular Health study J Am Coll Cardiol 43 2004 2236 2241
69. E.T. Poehlman Menopause, energy expenditure, and body composition Acta Obstet Gynecol Scand 81 2002 603 611
70. V. Carey, E. Walters, G. Colditz Body fat distribution and risk of non-insulin-dependent diabetes in women Am J Epidemiol 145 1997 614 619
71. A.R. Folsom, R.J. Prineas, S.A. Kaye, R.G. Munger Incidence of hypertension and stroke in relation to body fat distribution and other risk factors in older women Stroke 21 1990 701 706
72. S. Lamon-Fava, P.W.F. Wilson, E.J. Schaefer Impact of body mass index on coronary heart disease risk factors in men and women the Framingham Offspring study Arteriosler Thromb Vasc Biol 16L 1996 1509 1515
73. K.M. Rexrode, V.J. Carey, C.H. Hennekens Abdominal adiposity and coronary heart disease in women JAMA 280 1998 1843 1850
74. A. Onat, G.S. Avci, M.M. Barlan, H. Uyarel, B. Uzunlar, V. Sansoy Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk Int J Obes Relat Metab Disord 28 2004 1018 1025
75. D.A. Lawlor, G.D. Smith, S. Ebrahim Association between childhood socioeconomic status and coronary heart disease risk among postmenopausal women Am J Public Health 94 2004 1386 1392
76. T.R. Wessel, C.B. Arant, M.B. Olson Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women JAMA 292 2004 1179 1187
77. K.M. Flegal, M.D. Carroll, C.L. Ogden, C.L. Johnson Prevalence and trends in obesity among U.S. adults, 1999-2000 JAMA 288 2002 1723 1727
78. Overweight and Obesity: Obesity Trends: U.S. Obesity Trends 1985-2004. Available at: www.cdc.gov/nccdphp/dnpa/obesity/trend/maps/index.htm. Accessed November 23, 2005.
79. Preventive Cardiology How Can We Do Better? 2001 Presented at: the 33rd Bethesda Conference, Bethesda, Maryland, December 18, Available at: www.acc.org/clinical/bethesda/beth33/index.htm. Accessed November 23, 2005
80. T.Y. Goraya, C.L. Leibson, P.J. Palumbo Coronary atherosclerosis in diabetes mellitus a population-based autopsy study J Am Coll Cardiol 40 2002 946 953
81. M.J. Legato Dyslipidemia, gender, and the role of high-density lipoprotein cholesterol implications for therapy Am J Cardiol 86 2000 15L 18L
82. F. Ledru, P. Ducimetiere, S. Battaglia New diagnostic criteria for diabetes and coronary artery disease insights from an angiographic study J Am Coll Cardiol 37 2001 1543 1550
83. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Available at: www.nhlbi.nih.gov/guidelines/cholesterol/index.htm. Accessed November 23, 2005.
84. The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) JAMA 285 2001 2486 2497
85. N.D. Wong, M.G. Sciammarella, D. Polk The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium J Am Coll Cardiol 41 2003 1547 1553
86. K.E. Kip, O.C. Marroquin, D.E. Kelley Clinical importance of obesity versus the metabolic syndrome on cardiovascular risk in women a report from the Women's Ischemia Syndrome Evaluation (WISE) Circulation 109 2004 706 713
87. B. Isomaa, P. Almgren, T. Tuomi Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 24 2001 683 689
88. H.-M. Lakka, D.E. Laaksonen, T.A. Lakka The metabolic syndrome and total and cardiovascular mortality in middle aged men JAMA 288 2002 2709 2716
89. P.M. Ridker, J.E. Buring, N.R. Cook, N. Rifai C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events an 8-year follow-up of 14,719 initially healthy American women Circulation 107 2003 391 397
90. O.C. Marroquin, K.E. Kip, D. Kelley The metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women a report from WISE Circulation 1009 2004 714 721
91. I. Lofgren, K. Herron, T. Zern Waist circumference is a better predictor than body mass index of coronary heart disease risk in overweight premenopausal women J Nutr 134 2004 1071 1076
92. J. Lord, T. Wilkin Polycystic ovary syndrome and fat distribution the central issue? Hum Fertil (Camb) 5 2002 67 71
93. L.S. Kinder, M.R. Carnethon, L.P. Palaniappan, A.C. King, S.P. Fortmann Depression and the metabolic syndrome in young adults findings from the Third National Health and Nutrition Examination survey Psychosom Med 66 2004 316 322
94. H.S. Lett, J.A. Blumenthal, M.A. Babyak Depression as a risk factor for coronary artery disease evidence, mechanisms, and treatment Psychosom Med 66 2004 305 315
95. R. Paoletti, P.G. Cosignani, P. Kenemans Menopause problems and interventions in the United States R. Paoletti P.G. Cosignani P. Kenemans G. Samsoe M. Soma A.S. Jackson Women's Health and Menopause 1997 Kluwer Academic Publishers Norwell, MA 9 14
96. M.R. Adams, J.R. Kaplan, S.B. Manuck Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys lack of an effect of added progesterone Atherosclerosis 10 1990 1051 1057
97. J.D. Wagner, T.B. Clarkson, R.W. S. Clair, D.C. Schwenke, C.A. Shively, M.R. Adams Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys J Clin Invest 88 1991 1995 2002
98. J.R. Kaplan, S.B. Manuck, M.S. Anthony, T.B. Clarkson Premenopausal social status and hormone exposure predict postmenopausal atherosclerosis in female monkeys Obstet Gynecol 99 2002 381 388
99. C.N. Bairey Merz, B.D. Johnson, B.L. Sharaf Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women a report from the NHLBI-sponsored WISE study J Am Coll Cardiol 41 2003 413 419
100. C.N. Bairey Merz Oral contraceptives, reproductive history and angiographic coronary artery disease in women data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Fertil Steril 2006 In press
101. M.K. Ng, C.M. Quinn, J.A. McCrohon Androgens up-regulate atherosclerosis-related genes in macrophages from males but not females molecular insights into gender differences in atherosclerosis J Am Coll Cardiol 42 2003 1306 1313
102. L.E. Chambless, G. Heiss, E. Shahar, M.J. Earp, J. Toole Prediction of ischemic stroke risk in the Atherosclerosis Risk in Communities study Am J Epidemiol 160 2004 259 269
103. E.S. Ford, W.H. Giles, A.H. Mokdad The distribution of 10-year risk for coronary heart disease among U.S. adults findings from the National Health and Nutrition Examination Survey III J Am Coll Cardiol 43 2004 1791 1796
104. L.J. Shaw, J.F. Lewis, M.A. Hlatky Women's Ischemic Syndrome Evaluation: current status and future research directions, report of the National Heart Lung Blood Institute (NHLBI) workshop, section 5: gender-related risk factors for ischemic heart disease, October 2-4, 2002 Circulation 109 2004 56e 58e
105. P. Raggi, L.J. Shaw, D.S. Berman, T.Q. Callister Gender-based differences in the prognostic value of coronary calcium J Women Health 13 2004 273 288
106. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
107. P.M. Ridker, J.E. Buring, J. Shih, M. Matias, C.H. Hennekens Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women Circulation 98 1998 731 733
108. T.Y. Wong, L.D. Hubbard, R. Klein Retinal microvascular abnormalities and blood pressure in older people the Cardiovascular Health study Br J Ophthalmol 86 2002 1007 1013
109. N.M. Bressler Retinal arteriolar narrowing and risk of coronary heart disease Arch Ophthalmol 121 2003 113 114
110. T.Y. Wong, R. Klein, A.R. Sharrett Retinal arteriolar narrowing and risk of coronary heart disease in men and women JAMA 287 2002 1153 1159
111. L.D. Hubbard, R.J. Brothers, W.N. King Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk In Communities (ARIC) study Ophthalmology 106 1999 2269 2280
112. H.S. Hecht, H.R. Superko Electron beam tomography and National Cholesterol Education Program guidelines in asymptomatic women J Am Coll Cardiol 37 2001 1506 1511
113. R.F. Redberg, N. Rifai, L. Gee, P.M. Ridker Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women implications for coronary artery disease screening J Am Coll Cardiol 36 2000 39 43
114. L.H. Kuller, R.P. Tracy The role of inflammation in cardiovascular disease Arterioscler Thromb Vasc Biol 20 2000 901 906
115. R.P. Tracy Inflammation in cardiovascular disease cart, horse or both - revisited Arterioscler Thromb Vasc Biol 22 2002 1514 1515
116. T.A. Pearson, G.A. Mensah, R.W. Alexander Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511
117. J. Cosin-Sales, C. Pizzi, S. Brown, J.C. Kaski C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms J Am Coll Cardiol 41 2003 1468 1474
118. N.D. Wong, J. Pio, R. Valencia, G. Thakal Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III Prev Cardiol 4 2001 109 114
119. M.A. Albert, R.J. Glynn, J. Buring, P.M. Ridker C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health study) Am J Cardiol 93 2004 1238 1242
120. American Autoimmune Related Diseased Association. Autoimmune Disease in Women: The Facts. Available at: http://www.aarda.org/women.php. Accessed November 23, 2005.
121. R. Bessant, A. Hingorani, L. Patel, A. MacGregor, D.A. Isenberg, A. Rahman Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus Rheumatology (Oxford) 43 2004 924 929
122. M.J. Roman, B.A. Shanker, A. Davis Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus N Engl J Med 349 2003 2399 2406
123. Y. Asanuma, A. Oeser, A.K. Shintani Premature coronary-artery atherosclerosis in systemic lupus erythematosus N Engl J Med 349 2003 2407 2415
124. C.B. Arant, T.R. Wessel, M.B. Olson National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation study. Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation study J Am Coll Cardiol 43 2004 2009 2014
125. P.S. Douglas, G.S. Ginsburg The evaluation of chest pain in women N Engl J Med 334 1996 1311 1315
126. K.A. Milner, M. Funk, A. Arnold, V. Vaccarino Typical symptoms are predictive of acute coronary syndromes in women Am Heart J 143 2002 283 288
127. J.C. McSweeney, M. Cody, P. O'Sullivan, K. Elberson, D.K. Moser, B.J. Garvin Women's early warning symptoms of acute myocardial infarction Circulation 108 2003 2619 2623
128. A. Rosengren, L. Wallentin, A. Gitt, S. Behar, A. Battler, D. Hasdai Sex, age, and clinical presentation of acute coronary syndromes Eur Heart J 25 2004 663 670
129. G.A. Diamond, J.S. Forrester Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease N Engl J Med 300 1979 1350 1358
130. B.D. Johnson, S.F. Kelsey, C.N. Bairey Merz Clinical risk assessment in women: chest discomfort. Report from the WISE study L.J. Shaw R.F. Redberg Coronary Disease in Women Evidence-Based Diagnosis and Treatment 2003 Humana Press Totowa, NJ 129 142
131. B.L. Sharaf, C.J. Pepine, R.A. Kerensky Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] study angiographic core laboratory) Am J Cardiol 87 2001 937 941 A3
132. M.J. Zellweger, R. Hachamovitch, X. Kang Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients Eur Heart J 25 2004 543 550
133. A.A. Chun, S.R. McGee Bedside diagnosis of coronary artery disease a systematic review Am J Med 117 2004 334 343
134. L.P. Kimble, D.B. McGuire, S.B. Dunbar Gender differences in pain characteristics of chronic stable angina and perceived physical limitation in patients with coronary artery disease Pain 101 2003 45 53
135. D. Klingler, R. Green-Weir, D. Nerenz Perceptions of chest pain differ by race Am Heart J 144 2002 51 59
136. C. Gorman Koch, C. Mora Mangano, N. Schwann, V. Vaccarino Is it gender, methodology, or something else? Thorac Cardiovasc Surg 126 2003 932 935
137. K.A. Kyker, M.C. Limacher Gender differences in the presentation and symptoms of coronary artery disease Curr Womens Health Rep 2 2002 115 119
138. L.J. Shaw, B.L. Sharaf, B.D. Johnson Healthcare costs for cardiovascular disease in women with and without obstructive coronary disease results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) J Am Coll Cardiol 43 2004 422A
139. C.F. Emery, D.J. Frid, T.O. Engebretson Gender differences in quality of life among cardiac patients Psychosom Med 66 2004 190 197
140. N.B. Bairey Merz, B.D. Johnson, P.S.F. Kelsey Diagnostic, prognostic, and cost assessment of coronary artery disease in women Am J Managed Care 7 2001 959 965
141. T.D. Miller, V.L. Roger, D.O. Hodge, M.R. Hopfenspirger, K.R. Bailey, R.J. Gibbons Gender differences and temporal trends in clinical characteristics, stress test results and use of invasive procedures in patients undergoing evaluation for coronary artery disease J Am Coll Cardiol 38 2001 690 697
142. R.J. Gibbons, G.J. Balady, J. Timothy Bricker ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to update the 1997 exercise testing guidelines) J Am Coll Cardiol 40 2002 1531 1540
143. Diagnosis and Treatment of Coronary Heart Disease in Women Systematic Reviews of Evidence on Selected Topics 2003 Agency for Healthcare Research and Quality Rockville, MD Summary, Evidence Report/Technology Assessment: Number 81. AHRQ Publication No. 03-E036, MayAvailable at: http://www.ahrq.gov/clinic/ epcsums/chdwtopsum.htm. Accessed November 23, 2005
144. Results of Systematic Review of Research on Diagnosis and Treatment of Coronary Heart Disease in Women 2003 Agency for Healthcare Research and Quality Rockville, MD Summary, Evidence Report/Technology Assessment: Number 80. AHRQ Publication No. 03-E034, May. Available at: http://www.ahrq.gov/clinic/epcsums/ chdwomsum.htm. Accessed November 23, 2005
145. M.A. Hlatky, D.B. Pryor, F.E. Harrel Jr. Factors affecting sensitivity and specificity of exercise electrocardiography multivariable analysis Am J Med 77 1984 64 71
146. Y.S. Kwok, C. Kim, D. Grady Meta-analysis of exercise testing to detect coronary artery disease in women Am J Cardiol 83 1999 660 666
147. L.J. Shaw, M.B. Olson, K. Kip The value of estimated functional capacity in estimating outcome the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study J Am Coll Cardiol 47 Suppl A 2006 36A 43A
148. C.M. Webb, G.M.C. Rosano, P. Collins Oestrogen improves exercise-induced myocardial ischemia in women Lancet 351 1998 1556 1559
149. G.W. Lloyd, N.R. Patel, E. McGing, A.F. Cooper, D. Brennand-Roper, G. Jackson Does angina vary with the menstrual cycle in women with premenopausal coronary artery disease? Heart 84 2000 189 192
150. D.D. Waters, D. Gordon, J.E. Rossouw Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: section 4: lessons from hormone replacement trials Circulation 109 2004 e53 e55
151. G.M. Rosano, C.M. Webb, S. Chierchia Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women J Am Coll Cardiol 36 2000 2154 2159
152. H. Kawano, T. Motoyama, K. Ohgushi Menstrual cyclic variation of myocardial ischemia in premenopausal women with variant angina Ann Intern Med 135 2001 977 981
153. A.P. Morise, J.N. Dalal, R.D. Duval Frequency of oral estrogen replacement therapy in women with normal and abnormal exercise electrocardiograms and normal coronary arteries by angiogram Am J Cardiol 72 1993 1197 1199
154. H. Kawano, T. Motoyama, M. Ohgushi, K. Kugiyama, H. Ogawa, H. Yasue Menstrual cyclic variation of myocardial ischemia in premenopausal women with variant angina Ann Intern Med 135 2001 977 981
155. H. Kawano, T. Motoyama, N. Hirai, K. Kugiyama, H. Ogawa, H. Yasue Estradiol supplementation suppresses hyperventilation-induced attacks in postmenopausal women with variant angina J Am Coll Cardiol 37 2001 735 740
156. S.P. Schulman, D.R. Thiemann, P. Ouyang Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina J Am Coll Cardiol 39 2002 231 237
157. A.P. Morise, M.S. Lauer, V.F. Froelicher Development and validation of a simple exercise test score for use in women with symptoms of suspected coronary artery disease Am Heart J 144 2002 818 825
158. A.P. Morise, J.N. Dalal, R.D. Duval Value of a simple measure of estrogen status for improving the diagnosis of coronary artery disease in women Am J Med 94 1993 491 496
159. A.P. Morise, W.J. Haddad Validation of estrogen status as an independent predictor of coronary artery disease presence and extent in women J Cardiovasc Risk 3 1996 507 511
160. A.P. Morise, F. Jalisi Evaluation of pretest and exercise test scores to assess all-cause mortality in unselected patients presenting for exercise testing with symptoms of suspected coronary artery disease J Am Coll Cardiol 42 2003 842 850
161. T. Kavanagh, D.J. Mertens, L.F. Hamm Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation J Am Coll Cardiol 42 2003 2139 2143
162. M. Gulati, D.K. Pandey, M.F. Arnsdorf Exercise capacity and the risk of death in women Circulation 108 2003 1554 1559
163. S. Mora, R.F. Redberg, Y. Cui Ability of exercise resting to predict cardiovascular and all-cause death in asymptomatic women JAMA 290 2003 1600 1607
164. D.D. von Dras, I.C. Siegler, R.B. Williams Surrogate assessment of coronary artery disease patients' functional capacity Soc Sci Med 44 1997 1491 1502
165. M.A. Hlatky, R.E. Boineau, M.B. Higginbotham A brief self-administered questionnaire to determine functional capacity (the Duke activity status index) Am J Cardiol 64 1980 644 651
166. C.N. Bairey Merz, M. Olson, S. McGorray Physical activity and functional capacity measurement in women a report from the NHLBI-sponsored WISE study J Women's Health 9 2000 769 777
167. P.M. Okin, P.M. Kligfield Gender-specific criteria and performance of the exercise electrocardiogram Circulation 92 1995 1209 1216
168. M.S. Lauer, V. Froelicher Abnormal heart-rate recovery after exercise Lancet 360 2002 1176 1177
169. K. Shetler, R. Marcus, V.F. Froelicher Heart rate recovery validation and methodologic issues J Am Coll Cardiol 38 2001 1980 1987
170. B.R. Chaitman Abnormal heart rate responses to exercise predict increased long-term mortality regardless of coronary disease extent the question is why? J Am Coll Cardiol 42 2003 839 841
171. D.P. Vivekananthan, E.H. Blackstone, C.E. Pothier, M.S. Lauer Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease J Am Coll Cardiol 42 2003 831 838
172. L. Lind, B. Andren Heart rate recovery after exercise is related to the insulin resistance syndrome and heart rate variability in elderly men Am Heart J 144 2002 580 582
173. C. Panzer, M.S. Lauer, A. Brieke, E. Blackstone, B. Hoogwerf Association of fasting plasma glucose with heart rate recovery in healthy adults a population-based study Diabetes 51 2002 803 807
174. J.H. Mieres, L.J. Shaw, R.C. Hendel American Society of Nuclear Cardiology task force on women and coronary artery disease J Nucl Cardiol 10 2003 95 101
175. R. Taillefer, E.G. DePuey, J.E. Udelson, G.A. Beller, Y. Latour, F. Reeves Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG gated SPECT) in detecting coronary artery disease in women J Am Coll Cardiol 29 1997 69 77
176. F.J. Klocke, M.G. Baird, B.H. Lorell American College of Cardiology, American Heart Association, American Society for Nuclear Cardiology ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - executive summary a report of the American College of Cardiology/American Heart Association task force on practice guidelines (ACC/AHA/ASNC committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging) J Am Coll Cardiol 42 2003 1318 1333
177. D.S. Berman, X. Kang, S.W. Hayes Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management J Am Coll Cardiol 41 2003 1125 1133
178. A.M. Amanullah, D.S. Berman, R. Hachamovitch, H. Kiat, X. Kang, J.D. Friedman Identification of severe or extensive coronary artery disease in women by adenosine technetium-99m sestamibi SPECT Am J Cardiol 80 1997 132 137
179. M. Travin, M. Duca, G. Kline, S. Herman, D. Demus, G. Heller Relation of gender to physician use of test results and prognostic value of technetium 99m myocardial single-photon emission computed tomography scintigraphy Am Heart J 134 1997 78 82
180. R. Hachamovitch, D. Berman, H. Kiat Effective risk stratification using exercise myocardial perfusion single-photon emission computed tomography SPECT in women gender-related differences in prognostic nuclear testing J Am Coll Cardiol 28 1996 24 44
181. T.H. Marwick, L.J. Shaw, M.S. Lauer Economics of Noninvasive Diagnosis (END) Study Group The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease Am J Med 106 1999 172 178
182. L.J. Shaw, A.E. Iskandrian Prognostic value of stress gated SPECT in patients with known or suspected coronary artery disease J Nucl Cardiol 11 2004 171 185
183. S. Giri, L.J. Shaw, D.R. Murthy Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease Circulation 105 2002 32 40
184. S.L. Mulvagh, A.N. DeMaria, S.B. Feinstein Contrast echocardiography current and future applications J Am Soc Echo 13 2000 331 342
185. L.J. Shaw, C. Vasey, S. Sawada, C. Rimmerman, T.H. Marwick Impact of gender on risk stratification by exercise and dobutamine stress echocardiography long-term mortality in 4,234 women and 6,898 men Eur Heart J 26 2005 447 456
186. T.H. Marwick, C. Case, D. Poldermans A clinical and echocardiographic score for assigning risk of major events after dobutamine echocardiograms J Am Coll Cardiol 43 2004 2102 2107
187. R. Sicari, E. Pasanisi, L. Venneri, P. Landi, L. Cortigiani, E. Picano Echo Persantine International Cooperative (EPIC) Study Group Echo Dobutamine International Cooperative (EDIC) Study Group Stress echo results predict mortality a large-scale multicenter prospective international study J Am Coll Cardiol 41 2003 589 595
188. G.M. Pohost, R.W. Biederman, M. Doyle Cardiovascular magnetic resonance imaging and spectroscopy in the new millennium Curr Probl Cardiol 25 2000 525 620
189. J.R. Panting, P.D. Gatehouse, G.Z. Yang Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging N Engl J Med 346 2002 1948 1953
190. J.T. Keijer, A.C. van Rossum, M.J. van Eenige Magnetic resonance imaging of regional perfusion in patients with single-vessel coronary artery disease J Magn Reson Imaging 11 2000 607 615
191. E. Nagel, H.B. Lehmkuhl, W. Bocksch Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI comparison with dobutamine stress echocardiography Circulation 99 1999 763 770
192. W.Y. Kim, P.G. Danias, M. Stuber Coronary magnetic resonance angiography for the detection of coronary stenoses N Engl J Med 345 2001 863 869
193. S.D. Buchthal, J.A. Den Hollander, K. Hee-Won Metabolic evidence of myocardial ischemia by 31-P NMR spectroscopy in women with chest pain by no significant coronary stenoses pilot phase results from the NHLBI WISE study N Engl J Med 342 2000 829 835
194. B.D. Johnson, L.J. Shaw, S. Buchtal Myocardial ischemia in symptomatic women in the absence of obstructive coronary disease - prognosis and cost results from the NIH-NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Circulation 109 2004 2993 2999
195. G.A. Lanza, A. Sestito, G. Cammarota Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X Am J Cardiol 94 2004 40 44